Inglés

New Anticancer Treatment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 formularios  
New Anticancer Treatment
Descripción

New Anticancer Treatment

First Treatment Regimen:
Descripción

The patient has received new or additional anticancer treatment for NSCLC since discontinuing study drug. Record treatment and start date:

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0007131
Start Date
Descripción

Anticancer Treatment Start Date

Tipo de datos

date

Alias
UMLS CUI [1]
C3173309
Volver a la parte superior de la página

Similar models

New Anticancer Treatment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
New Anticancer Treatment
New Anticancer Treatment for NSCLC
Item
First Treatment Regimen:
text
C0087111 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
Anticancer Treatment Start Date
Item
Start Date
date
C3173309 (UMLS CUI [1])
Volver a la parte superior de la página